Header Logo

Connection

Naoko Takebe to Patched-1 Receptor

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Patched-1 Receptor.
Naoko Takebe
Connection Strength
0.241
Patched-1 Receptor
  1. Phase II Study of Vismodegib in Patients With SMO- or PTCH1-Mutated Tumors: Results From the National Cancer Institute Molecular Analysis for Therapy Choice Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Trial (EAY131) Subprotocol T. JCO Precis Oncol. 2025 Oct; 9:e2500119.
    View in: PubMed
    Score: 0.241
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.